Jun 2014

Bio International Convention (June 23-26, 2014)

Mr. Amir Weisberg and Mr. Asaf Bar will present PolyPid and its technology as part of the Israeli pavilion at the 2014 Bio International Convention,to be held at the San Diego Convention Center, San Diego, California, June 23-26, 2014.

May 2014

Biomed (May 20-22, 2014)

PolyPid participated at Biomed – Israel Innovation Conference, held at the Tel Aviv Fairgrounds, Tel Aviv, Israel, May 20-22, 2014.

Mar 2014

AAOS Annual Meeting (March 11-15, 2014)

Mr. Amir Weisberg PolyPid’s CEO, Prof. David Segal and Mr. Eitan Kiet, participated at the annual meeting of the American Academy of Orthopaedic Surgeons, held in New Orleans, Louisiana, March 11-15, 2014. They met with doctors, thought leaders, and companies.

Mar 2014

7th Annual European Life Science CEO Forum for Partnering & Investing in Biotech & Pharma Industry (March 4-5, 2014)

Dr. Noam Emanuel, PolyPid’s CTO, presented the company at the 7th Annual European Life Science CEO Forum for Partnering & Investing in Biotech & Pharma Industry, held at the Hilton Zurich Airport Hotel, Switzerland, March 4-5, 2014.

Technology

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that allows controlled, local release of unmodified drugs over extended periods of time.

Read More >

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >